References
Chadla M, Chabon AB, Friedman P, Vikram B. Predictors of axillary lymph node metastases inpatients with Tl breast cancer.Cancer 1994; 73: 350–355.
Horak ER, Russell L, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer.Lancet 1992; 340: 1120–1124.
Kao CH, Yang MD, Wang SJ, et al. The99mTc MIBI scintigraphy in the evaluation of mass abnormalities of the breast.Eur J Nucl Med 1993; 20: 979.
Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast massess.Eur J Nucl Med 1994; 21: 377–476.
Silverstein MJ, Gierson ED, Waishman R, et al. Axillary lymph node dissection for Tla breast carcinoma: is it indiated?Cancer 1994; 73: 664–667.
Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer.Cancer 1994; 73–505.
Weidner N, Semple JP, Welch WR. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma.N Engl J Med 1991; 324: 1–8.
Iewig OE, Kim WH, Wong WE Positron-emission tomography with fluorine-l8-deoxyglucose for detection and staging of breast cancer.Cancer 1993; 71: 3920–3925.
Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness.Eur J Nucl Med 1994; 21: 984–987.
Scopinaro F, Schillaci O, Di Macio L.99mTc sestamibi scan in breast cancer.Eur J Nucl Med 1993; 20: 979.
Pani R, Scopinaro F, De Paola G. Very high resolution gamma camera prototype.Phys Med 1993; 9: 233.
Pam R and the Hirespet Group. Multicrystal YAP: Cc detector for position sensitive measurements.Nucl Instrum Methods Phys Res Sect A 1994; 348: 551–558.
Barone ML and the Hirespet Group. Toward a nuclear medicin with submillimeter spatial resolution.INFN Internal Reports 1994; 1040: 1–15.
Scopinaro F, De Vincentis G, Pani R, et al.99mTc MIBI uptake in green plants.Nucl Med Commun 1994; 15: 905–915.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scopinaro, F., Schillaci, O. Reply. Eur J Nucl Med 22, 582–584 (1995). https://doi.org/10.1007/BF00817287
Issue Date:
DOI: https://doi.org/10.1007/BF00817287